Israel-based firm Pangea has introduced an end to end platform that aims to assist airlines and the tourism industry across the globe to get back to business amidst Covid-19. The company’s smart card acts as an immunity ‘passport’ which means that the cardholder is not infected and can travel to public places.

Empa researchers have succeeded in applying aerogels to microelectronics: Aerogels based on cellulose nanofibers can effectively shield electromagnetic radiation over a wide frequency range — and they are unrivalled in terms of weight.

Irrigated Scots pines in the dry Pfyn Forest (canton of Valais) had their water supply turned off after 11 years. The trees' response surprised the international research group as it suggests that tree growth is also influenced by past conditions. Trees, you might say, do not forget.

KPM Analytics announced the expansion of its senior leadership team with the addition of Maurice Janssen and Rainer Roehrig, who will report to founding Chief Executive Officer, Chris McIntire.

The organisers of the show, Messe Muenchen India has recently announced the cancellation of the Mumbai edition of Analytica Anacon India and India Lab Expo 2020 due to Covid-19.The shows were earlier rescheduled to August 2020.

The U.S. FDA has given the nod to Pfizer and Biontech to fast track two investigational mRNA-based vaccine candidates against Sars-Cov-2. Both the companies are expected to manufacture 100 million doses by the end of 2020, if it receives regulatory approval.

An ultrathin, lightweight, porous polymeric membrane designed at Kaust can turn the N95 respirator into a reusable facemask while potentially improving its ability to keep out Sars-Cov-2, the virus that causes Covid-19.

A research group led by Daniel Aili, associate professor at LIU, has developed a bioink to print tissue-mimicking material in 3D printers. The scientists have developed a method and a material that allow cells to survive and thrive.

Italian biotech company Rigenerand has commenced development of a novel 3D bioreactor and pipeline, specifically designed for the incremental production of extracellular vesicles exosomes (EVs) in a cGMP environment. The company’s project development will be supported with part of a grant of $ 5 million from Horizon 2020 for the H2020-EU.1.2.2.-FET Proactive program, awarded to the Biogenic Organotropic Wetsuits project. This project comprises a consortium of companies involving Rigenerand.

Absolute Antibody and the University of Zurich aim to offer synthetic nanobodies against the receptor binding domain of Sars-Cov-2 which is responsible for causing Covid-19. The antibodies can be used for coronavirus diagnostics and therapeutic development.